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Background: General anesthetics (GA) are associated with neurodevelopmental abnormalities including cell
death, cognitive and behavioral changes. There is now powerful evidence for non-cell autonomous mechanisms in
almost every pathological condition in the brain, especially relevant to glial cells, mainly astrocytes and microglia,
that exhibit structural and functional contacts with neurons. These interactions were recently reported to occur via
the secretion of extracellular vesicles (EVs). Here, we employed primary human neural cells to analyze ketamine
effects focusing on the functions of glial cells and their polarization/differentiation state. We also explored the roles
of extracellular vesicles (EVs) and different components of the BDNF pathway.
Methods: Ketamine effects were analyzed on human neuronal and glial cell proliferation and apoptosis and
astrocytic (A1/A2 ) and microglial (M1/M2) cell activation were analyzed. The impact of the neuron-glial cell
interactions in the neurotoxic effects of ketamine was analyzed using transwell co-cultures. The role of the brainderived neurotrophic factor (BDNF) pathway, was analyzed using RT-PCR, ELISA western blot and gene
silencing. EVs secreted by ketamine-treated cells were isolated, characterized and analyzed for their effects in
neuron-glia cell interactions. Data were analyzed using analysis of variance or a Student's t test with correction for
data sets with unequal variances.
Results: Ketamine induced neuronal and oligodendrocytic cell apoptosis and promoted the expression of proinflammatory astrocytes (A1) and microglia (M1) phenotypes. Astrocytes and microglia enhanced the neurotoxic
effects of ketamine on neuronal cells, whereas neurons increased oligodendrocyte cell death. Ketamine modulated
different components in the BDNF pathway: decreasing BDNF secretion in neurons and astrocytes while increasing
the expression of p75 in neurons and oligodendrocytes. In addition, ketamine treatment increased the lncRNA
BDNF-AS levels and the secretion of pro-BDNF secretion. We found an important role of EVs secreted by
ketamine-treated astrocytes in neuronal cell death by delivering BDNF-AS.
Conclusions: Ketamine neurotoxicity involves both autonomous and non-cell autonomous mechanisms
andomponents of the BDNF pathway expressed by neurons and glial cells represent major regulators of ketamine
effects. We demonstrated for the first time a role of EVs as important mediators of ketamine effects by the delivery
of specific non-coding RNAs. These results may contribute to a better understanding of cellular and molecular
mechanisms underlying ketamine neurotoxic effects in humans and to the development of potential approaches to

GLIA 2021 | POSTER ABSTRACTS

E303

decrease its neurodevelopmental impact.
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Neural-glia interactions mediate the loss of perisomatic inhibitory
synapses in Toxoplasma gondii infection
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Prolonged infection and inflammation within the brain can alter the connectivity and function of neuronal circuits.
The intracellular protozoan parasite, Toxoplasma gondii, is one pathogen that can chronically infect the brain and
lead to encephalitis and seizures. Currently, 1 in 3 humans are infected with Toxoplasma gondii worldwide, and
these infections have been identified as a considerable risk factor for developing complex neurological and
psychiatric disorders that arise from alterations in assembly and maintenance of synapses, such as schizophrenia.
To directly assess changes in inhibitory synapses, we employed serial block face scanning electron microcopy and
quantified perisomatic synapses in neocortex and hippocampus following parasitic infection. Ultrastructural
analyses, in combination with genetic and immunohistochemical tools, revealed that persistent infection not only
led to a significant loss of inhibitory perisomatic synapses, it also induced the ensheathment of neuronal somata
and perisomatic nerve terminals by activated myeloid-derived cells (including microglia), suggesting they may
displace or phagocytose synaptic elements in long-term infection. How might microglia contribute to inhibitory
synapse loss in parasitic infection? One potential mechanism is the innate complement cascade, an immune

